HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants-Reference-Cited by-同舟云学术

HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants

Published:2021-03-09 Issue:6 Volume:7 Page:1469-1482
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Smith Steven J.¹,Zhao Xue Zhi²,Passos Dario Oliveira³,Pye Valerie E.⁴,Cherepanov Peter⁴⁵,Lyumkis Dmitry³⁶,Burke Terrence R.²^ORCID,Hughes Stephen H.¹^ORCID

Affiliation:

1. HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States

2. Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States

3. Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, United States

4. Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London NW1 1AT, U.K.

5. St Mary’s Hospital, Department of Infectious Disease, Imperial College London, Section of Virology, Norfolk Place, London W2 1PG, U.K.

6. Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, United States

Funder

Francis Crick Institute

National Institute of Allergy and Infectious Diseases

Wellcome Trust

National Institute of General Medical Sciences

Margaret T. Morris Foundation

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00819

Reference63 articles.

1. Success and failure of initial antiretroviral therapy in adults

2. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

3. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer

4. Retroviral intasome assembly and inhibition of DNA strand transfer

5. Cabotegravir Plus Rilpivirine: First Approval

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions;Viruses;2024-02-21

2. N-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants;ACS Infectious Diseases;2024-02-12

3. New Perspective for Using Antimicrobial and Cell-Penetrating Peptides to Increase Efficacy of Antineoplastic 5-FU in Cancer Cells;Journal of Functional Biomaterials;2023-12-12

4. Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants;Science Advances;2023-07-21

5. A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants;Archives of Microbiology;2023-03-26